Metreleptin for Lipodystrophy Conditions
MEASuRE: Metreleptin Effectiveness And Safety Registry
Recruiting
Observational Study
Generalised Lipodystrophy
Partial Lipodystrophy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
Who this trial is looking for
This trial is looking for patients who have been treated with metreleptin. Participants will join a registry to help track the effectiveness and safety of this treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am currently being treated with metreleptin
- I provide written consent
- I am coming off a clinical study and will continue metroleptin
You may not be able to join if
- I am currently treated with a study medication from a clinical trial
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients treated with metreleptin through commercial supply at the time or before enrolment into registry
* Patients who provide a written consent
* Patient coming off metreleptin clinical studies and continuing or restarting treatment with metreleptin through commercial suppl…
Contacts